Psychotropic Drug-Induced Glaucoma: A Practical Guide to Diagnosis and Management

Abstract

This article provides a practical review of the diagnosis and management of angle closure induced by psychotropic agents, including tricyclic antidepressants, antipsychotics and anticonvulsants. Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors and antipsychotics may trigger angle closure by influencing pupil configuration through adrenergic, anticholinergic, serotonergic or dopaminergic mechanisms. Patients with narrow iridocorneal angles are at risk, and these are more common in people with hypermetropia (near-sightedness), older people and individuals with an Asian background. These patients may benefit from a laser peripheral iridotomy, either prophylactically or to relieve an acute angle-closure episode. An idiosyncratic reaction to medications such as topiramate may lead to angle closure through an alternate mechanism, leading to a uveal effusion. Ophthalmological review may be considered prior to commencing medications in high-risk patients.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Li J, Tripathi RC, Tripathi BJ. Drug-induced ocular disorders. Drug Saf. 2008;31(2):127–41.

    PubMed  Google Scholar 

  2. 2.

    Congdon NG, Friedman DS. Angle-closure glaucoma: impact, etiology, diagnosis, and treatment. Curr Opin Ophthalmol. 2003;14(2):70–3.

    PubMed  Google Scholar 

  3. 3.

    Razeghinejad M, Myers J, Katz L. Iatrogenic glaucoma secondary to medications. Am J Med. 2011;124(1):20–5.

    CAS  PubMed  Google Scholar 

  4. 4.

    Khurana AK, Khurana B, Khurana AK. Drug-induced angle-closure glaucoma. J Curr Glaucoma Pract. 2012;6(1):6–8.

    PubMed  PubMed Central  Google Scholar 

  5. 5.

    Lachkar Y, Bouassida W. Drug-induced acute angle-closure glaucoma. Curr Opin Ophthalmol. 2007;18(2):129–33.

    PubMed  Google Scholar 

  6. 6.

    Razeghinejad M, Pro M, Katz L. Non-steroidal drug-induced glaucoma. Eye. 2011;25(8):971–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Lee GC, Tam CP, Danesh-Meyer HV, Myers JS, Katz LJ. Bilateral angle-closure glaucoma induced by sulphonamide-derived medications. Clin Exp Ophthalmol. 2007;35(1):55–8.

    PubMed  Google Scholar 

  8. 8.

    Fraunfelder F, Fraunfelder F, Keates EU. Topiramate-associated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology. 2004;111(1):109–11.

    CAS  PubMed  Google Scholar 

  9. 9.

    Richa S, Yazbek J-C. Ocular adverse effects of common psychotropic agents. CNS Drugs. 2010;24(6):501–26.

    CAS  PubMed  Google Scholar 

  10. 10.

    Levy J, Yagev R, Petrova A, Lifshitz T. Topiramate-induced bilateral angle-closure glaucoma. Can J Ophthalmol. 2006;41(2):221–5.

    PubMed  Google Scholar 

  11. 11.

    Rhee DJ, Goldberg MJ, Parrish RK. Bilateral angle-closure glaucoma and ciliary body swelling from topiramate. Arch Ophthalmol. 2001;119(11):1721–3.

    CAS  PubMed  Google Scholar 

  12. 12.

    Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of topiramate-induced acute-onset myopia and angle-closure glaucoma. Am J Ophthalmol. 2004;137(1):193–5.

    PubMed  Google Scholar 

  13. 13.

    Abtahi M-A, Abtahi S-H, Fazel F, Roomizadeh P, Etemadifar M, Jenab K, et al. Topiramate and the vision: a systematic review. Clin Ophthalmol (Auckland, NZ). 2012;6:117.

    CAS  Google Scholar 

  14. 14.

    Leung D, Leung H, Baig N, Kwan P, Kwong Y, Wong K, et al. Topiramate and asymptomatic ocular angle narrowing: a prospective pilot study. Eye. 2009;23(11):2079–81.

    CAS  PubMed  Google Scholar 

  15. 15.

    Ozturk BT, Genc E, Tokgoz M, Kerimoglu H, Genc BO. Ocular changes associated with topiramate. Curr Eye Res. 2011;36(1):47–52.

    CAS  PubMed  Google Scholar 

  16. 16.

    Jabbarpoor Bonyadi MH, Soheilian R, Soheilian M. Topiramate-induced bilateral anterior uveitis associated with hypopyon formation. Ocul Immunol Inflamm. 2011;19(1):86–8.

    PubMed  Google Scholar 

  17. 17.

    Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Presumed topiramate-induced bilateral acute angle-closure glaucoma. Am J Ophthalmol. 2001;132(1):112–4.

    CAS  PubMed  Google Scholar 

  18. 18.

    Etminan M, Maberley D, Mikelberg FS. Use of topiramate and risk of glaucoma: a case-control study. Am J Ophthalmol. 2012;153(5):827–30.

    CAS  PubMed  Google Scholar 

  19. 19.

    Ho J-D, Keller JJ, Tsai C-Y, Liou S-W, Chang C-J, Lin H-C. Topiramate use and the risk of glaucoma development: a population-based follow-up study. Am J Ophthalmol. 2013;155(2):336-341.e1.

    CAS  PubMed  Google Scholar 

  20. 20.

    Tripathi RC, Tripathi BJ, Haggerty C. Drug-induced glaucomas. Drug Saf. 2003;26(11):749–67.

    CAS  PubMed  Google Scholar 

  21. 21.

    Ritch R, Krupin T, Henry C, Kurata F. Oral imipramine and acute angle-closure glaucoma. Arch Ophthalmol. 1994;112(1):67–8.

    CAS  PubMed  Google Scholar 

  22. 22.

    Schlingemann R, Smit A, Lunel HV, Hijdra A. Amaurosis fugax on standing and angle-closure glaucoma with clomipramine. The Lancet. 1996;347(8999):465.

    CAS  Google Scholar 

  23. 23.

    Subak-Sharpe I, Low S, Nolan W, Foster PJ. Pharmacological and environmental factors in primary angle-closure glaucoma. Br Med Bull. 2010;93(1):125–43.

    PubMed  Google Scholar 

  24. 24.

    Ahmad S. Fluoxetine and glaucoma. DICP. 1991;25(4):436.

    CAS  PubMed  Google Scholar 

  25. 25.

    Costagliola C, Parmeggiani F, Sebastiani A. SSRIs and intraocular pressure modifications. CNS Drugs. 2004;18(8):475–84.

    CAS  PubMed  Google Scholar 

  26. 26.

    Bennett H, Wyllie A. Paroxetine and acute angle-closure glaucoma. Eye. 1999;13(5):691–2.

    PubMed  Google Scholar 

  27. 27.

    Eke T, Bates A. Acute angle-closure glaucoma associated with paroxetine. BMJ Br Med J. 1997;314(7091):1387.

    CAS  Google Scholar 

  28. 28.

    Kirwan JF, Subak-Sharpe IAN, Teimory M. Bilateral acute angle-closure glaucoma after administration of paroxetine. Br J Ophthalmol. 1997;81(3):252.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Browning AC, Reck AC, Chisholm LH, Nischal KK. Acute angle-closure glaucoma presenting in a young patient after administration of paroxetine. Eye. 2000;14(3):406–8.

    PubMed  Google Scholar 

  30. 30.

    Lewis CF. Acute angle-closure glaucoma and paroxetine. J Clin Psychiatry. 1997;58:123–4.

    CAS  PubMed  Google Scholar 

  31. 31.

    Jiménez-Jiménez FJ, Ortí-Pareja M, Zurdo JM. Aggravation of glaucoma with fluvoxamine. Ann Pharmacother. 2001;35(12):1565–6.

    PubMed  Google Scholar 

  32. 32.

    Massaoutis P, Goh D, Foster P. Bilateral symptomatic angle-closure associated with a regular dose of citalopram, an SSRI antidepressant. Br J Ophthalmol. 2007;91(8):1086–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Croos R, Thirumalai S, Hassan S, Davis JDR. Citalopram associated with acute angle-closure glaucoma: case report. BMC Ophthalmol. 2005;5(1):23.

    PubMed  PubMed Central  Google Scholar 

  34. 34.

    Adverse Drug Reactions Advisory Committee. Australian Adverse Drug Reactions Bulletin. 2001. p. 3.

  35. 35.

    Yang MC, Lin KY. Drug-induced acute angle-closure glaucoma: a review. J Curr Glaucoma Pract. 2019;13(3):104–9.

    PubMed  PubMed Central  Google Scholar 

  36. 36.

    Shifera AS, Leoncavallo A, Sherwood M. Probable association of an attack of bilateral acute angle-closure glaucoma with duloxetine. Ann Pharmacother. 2014;48(7):936–9.

    PubMed  Google Scholar 

  37. 37.

    Ng B, Sanbrook GMC, Malouf AJ, Agarwal SA. Venlafaxine and bilateral acute angle-closure glaucoma. Med J Aust. 2002;176(5):241.

    PubMed  Google Scholar 

  38. 38.

    Ezra D, Storoni M, Whitefield L. Simultaneous bilateral acute angle-closure glaucoma following venlafaxine treatment. Eye. 2006;20(1):128–9.

    CAS  PubMed  Google Scholar 

  39. 39.

    Denis P, Charpentier D, Berros P, Touameur S. Bilateral acute angle-closure glaucoma after dexfenfluramine treatment. Ophthalmologica. 1995;209(4):223–4.

    CAS  PubMed  Google Scholar 

  40. 40.

    Lee JTL, Skalicky SE, Lin M-L. Drug-induced myopia and bilateral angle-closure secondary to Zolmitriptan. J Glaucoma. 2017;26(10):954–6.

    PubMed  Google Scholar 

  41. 41.

    de Guzman MHP, Thiagalingam S, Ong PY, Goldberg I. Bilateral acute angle-closure caused by supraciliary effusions associated with venlafaxine intake. Med J Aust. 2005;182(3):121–3.

    PubMed  Google Scholar 

  42. 42.

    Chen H-Y, Lin C-L, Lai S-W, Kao C-H. Association of selective serotonin reuptake inhibitor use and acute angle-closure glaucoma. J Clin Psychiatry. 2016;77(6):e692–6.

    PubMed  Google Scholar 

  43. 43.

    Symes RJ, Etminan M, Mikelberg FS. Risk of angle-closure glaucoma with bupropion and topiramate. JAMA Ophthalmol. 2015;133(10):1187–9.

    PubMed  Google Scholar 

  44. 44.

    Zelefsky JR, Fine HF, Rubinstein VJ, Hsu IS, Finger PT. Escitalopram-induced uveal effusions and bilateral angle-closure glaucoma. Am J Ophthalmol. 2006;141(6):1144–7.

    CAS  PubMed  Google Scholar 

  45. 45.

    Raj S, Kaur M, Srinivasarao K, Thattaruthody F, Kaushik S, Pandav SS. Mirtazapine-induced bilateral secondary angle-closure in a female. GMS Ophthalmol Cases. 2020;10:Doc29-Doc.

    Google Scholar 

  46. 46.

    Seitz DP, Campbell RJ, Bell CM, Gill SS, Gruneir A, Herrmann N, et al. Short-term exposure to antidepressant drugs and risk of acute angle-closure glaucoma among older adults. J Clin Psychopharmacol. 2012;32(3):403–7.

    CAS  PubMed  Google Scholar 

  47. 47.

    Achiron A, Aviv U, Mendel L, Burgansky-Eliash Z. Acute angle-closure glaucoma precipitated by olanzapine. Int J Geriatr Psychiatry. 2015;30(10):1101–2.

    PubMed  Google Scholar 

  48. 48.

    Shen E, Farukhi S, Schmutz M, Mosaed S. Acute angle-closure glaucoma associated with aripiprazole in the setting of plateau iris configuration. J Glaucoma. 2018;27(2):e40–3.

    PubMed  Google Scholar 

  49. 49.

    He M, Jiang Y, Huang S, Chang DS, Munoz B, Aung T, et al. Laser peripheral iridotomy for the prevention of angle-closure: a single-centre, randomised controlled trial. Lancet. 2019;393(10181):1609–18.

    PubMed  Google Scholar 

  50. 50.

    Rauscher FM, Parrish RK. Atypical angle-closures. Curr Opin Ophthalmol. 2008;19(2):107–14.

    PubMed  Google Scholar 

  51. 51.

    Parthasarathi S, Myint K, Singh G, Mon S, Sadasivam P, Dhillon B. Bilateral acetazolamide-induced choroidal effusion following cataract surgery. Eye. 2007;21(6):870–2.

    CAS  PubMed  Google Scholar 

  52. 52.

    Mancino R, Varesi C, Cerulli A, Aiello F, Nucci C. Acute bilateral angle-closure glaucoma and choroidal effusion associated with acetazolamide administration after cataract surgery. J Cataract Refract Surg. 2011;37(2):415–7.

    PubMed  Google Scholar 

  53. 53.

    Cole KL, Wang EE, Aronwald RM. Bilateral acute angle-closure glaucoma in a migraine patient receiving topiramate: a case report. J Emerg Med. 2012;43(2):e89–91.

    PubMed  Google Scholar 

  54. 54.

    Willett MC, Edward DP. Refractory topiramate-induced angle-closure glaucoma in a man: a case report. J Med Case Rep. 2011;5(1):33.

    PubMed  PubMed Central  Google Scholar 

  55. 55.

    Rhee DJ, Ramos-Esteban JC, Nipper KS. Rapid resolution of topiramate-induced angle-closure glaucoma with methylprednisolone and mannitol. Am J Ophthalmol. 2006;141(6):1133–4.

    CAS  PubMed  Google Scholar 

  56. 56.

    Zalta AH, Smith RT. Peripheral iridoplasty efficacy in refractory topiramate-associated bilateral acute angle-closure glaucoma. Arch Ophthalmol. 2008;126(11):1603–5.

    PubMed  Google Scholar 

  57. 57.

    Parikh R, Parikh S, Das S, Thomas R. Choroidal drainage in the management of acute angle-closure after topiramate toxicity. J Glaucoma. 2007;16(8):691–3.

    PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Richard J. Symes.

Ethics declarations

Competing interests

Neeranjali S. Jain, Claire W. Ruan, Shanil R. Dhanji, and Richard Symes have no conflicts of interest that are directly relevant to the content of this article.

Funding

No funding was used to assist with the preparation of this manuscript.

Author contributions

NSJ primary manuscript author, literature review and editing. CWR editing. SRD literature review and editing. RS conceptualization, supervisor and editing.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and material

Not applicable.

Code availability

Not applicable.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jain, N.S., Ruan, C.W., Dhanji, S.R. et al. Psychotropic Drug-Induced Glaucoma: A Practical Guide to Diagnosis and Management. CNS Drugs 35, 283–289 (2021). https://doi.org/10.1007/s40263-020-00790-w

Download citation